Recurrent Tumor clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • REMASTer: REcurrent Brain Metastases After SRS Trial

    open to eligible people ages 18 years and up

    Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.

    at UCLA

Our lead scientists for Recurrent Tumor research studies include .

Last updated: